Panel Discussion: Creating an Open Dialogue Between People Living with ALS & Drug Developers to Co-ordinate Therapeutic Development Priorities
Time: 2:45 pm
day: Day Two AM
Details:
- Hearing directly from people living with ALS – what are the most important priorities in ALS drug development?
- Discussing participant engagement and experiences from most recent clinical trials – what improvements can be made?
- Identifying the immediate impacts people living with ALS are looking for from novel drug development
